• Home
  • Technology
  • Gaming
  • Entertainment
  • World & Business
  • Science
  • Sports
  • AI
HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    • HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI
    AI

    Bristol Myers Squibb to Use Chai Discovery AI Models

    Chai Discovery announces BMS will deploy its Chai-3 models for new therapeutics.

    SG
    NR
    PG
    4 Sources, 42d ago, first seen 42d ago

    TLDR

    Joshua Meier, founder of Chai Discovery, posted that Bristol Myers Squibb will use the company's Chai-3 AI models to support discovery of new therapeutics. The announcement notes that Chai-3 has been rolled out to partners since the start of the year. Prior partners listed include Eli Lilly, Novartis, Pfizer, and argenx. Investor Sarah Guo replied that the team is sweeping large pharma and that the companies are seeing impact from the models.

    Combined views

    94K

    4 Sources, first seen 42d ago

    Combined views

    94K

    4 Sources, first seen 42d ago

    425 likes
    425 likes
    22 comments
    97 saves
    45 reposts

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    Featured Source
    22 comments
    97 saves
    45 reposts

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    Today's Rank

    —

    Not ranked yet

    Today's Rank

    —

    Not ranked yet

    4 Sources

    @joshim5Frontier drug discovery programs require frontier capabilities. Today, we’re excited to share that BMS will be using Chai’s models to support the discovery of new therapeutics. Since rolling out Chai-3 to partners at the start of this year, we’ve partnered with @EliLillyandCo, @Novartis, @Pfizer, @argenxglobal, and now @BMSnews. Many of the world’s leading biopharma companies are now using our models to go after diseases. Scientific discovery is the domain where access to frontier AI matters the most. At @ChaiDiscovery, we’ve seen first hand how our latest model generations can make the difference between discovering a molecule and not. We’re excited to work with @BMSnews to break new ground in medicine and science.
    @saranormousteam chai is doing a full sweep of large pharma — really excited that all these companies are seeing impact from the models
    @NaveenGRaoThese guys are on a tear! They are continuously bringing AI to big pharma...this has such a massive lever on society to bring life-saving and life-improving drugs to market, at scale, faster
    @gradypbRT @saranormous: team chai is doing a full sweep of large pharma — really excited that all these companies are seeing impact from the models

    4 Sources

    @joshim5Frontier drug discovery programs require frontier capabilities. Today, we’re excited to share that BMS will be using Chai’s models to support the discovery of new therapeutics. Since rolling out Chai-3 to partners at the start of this year, we’ve partnered with @EliLillyandCo, @Novartis, @Pfizer, @argenxglobal, and now @BMSnews. Many of the world’s leading biopharma companies are now using our models to go after diseases. Scientific discovery is the domain where access to frontier AI matters the most. At @ChaiDiscovery, we’ve seen first hand how our latest model generations can make the difference between discovering a molecule and not. We’re excited to work with @BMSnews to break new ground in medicine and science.
    @saranormousteam chai is doing a full sweep of large pharma — really excited that all these companies are seeing impact from the models
    @NaveenGRaoThese guys are on a tear! They are continuously bringing AI to big pharma...this has such a massive lever on society to bring life-saving and life-improving drugs to market, at scale, faster
    @gradypbRT @saranormous: team chai is doing a full sweep of large pharma — really excited that all these companies are seeing impact from the models